IRIS
ORLANDONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.776
EU - Europa 877
AS - Asia 459
AF - Africa 41
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.773
UA - Ucraina 224
SG - Singapore 180
SE - Svezia 126
IE - Irlanda 116
IT - Italia 114
TR - Turchia 98
DE - Germania 95
DK - Danimarca 87
CN - Cina 82
HK - Hong Kong 50
FI - Finlandia 49
KR - Corea 46
FR - Francia 37
CI - Costa d'Avorio 36
GB - Regno Unito 17
BE - Belgio 5
MA - Marocco 5
CA - Canada 3
CL - Cile 2
IN - India 2
AL - Albania 1
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
EU - Europa 1
IS - Islanda 1
JP - Giappone 1
LV - Lettonia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
Totale 3.158
Salva come PNG Salva come JPEG
Città #
Jacksonville 229
Chandler 228
Fairfield 198
Dublin 116
Wilmington 101
Ashburn 100
Boardman 99
Singapore 95
Seattle 84
Woodbridge 84
Houston 70
New York 59
Ann Arbor 52
Cambridge 50
Hong Kong 50
Lawrence 46
Princeton 46
San Mateo 46
Turin 46
Abidjan 36
San Diego 18
Des Moines 15
Beijing 10
Shanghai 9
Centro 8
Izmir 8
Buffalo 7
Falls Church 7
Guangzhou 7
Wuhan 6
Brussels 5
London 5
Naples 5
Helsinki 4
Los Angeles 4
Norwalk 4
Wuxi 4
Campobasso 3
Kilburn 3
San Jose 3
Clifton 2
Dallas 2
Hangzhou 2
Ottawa 2
Palermo 2
Pune 2
Redmond 2
Scandicci 2
Simi Valley 2
Venice 2
Washington 2
Acton 1
Ancona 1
Auburn Hills 1
Auckland 1
Chiswick 1
East Los Angeles 1
Jiaxing 1
Jinan 1
Kunshan 1
La Canada Flintridge 1
Ljubljana 1
Longyan 1
Macerata 1
Nanjing 1
North Bergen 1
Ozzano Monferrato 1
Pesaro 1
Porto 1
Prescot 1
Reykjavik 1
Riga 1
Seoul 1
Solon 1
São Carlos do Ivaí 1
Taiyuan 1
Tallinn 1
Tiantai Chengguanzhen 1
Tirana 1
Toronto 1
Xiamen 1
Yiwu 1
Totale 2.023
Salva come PNG Salva come JPEG
Nome #
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 184
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 131
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 92
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 84
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 84
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 81
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 80
EFFECT OF PLATELET RICH PLASMA CONCENTRATION ON SKELETAL MUSCLE REGENERATION: AN EXPERIMENTAL STUDY 79
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 78
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 78
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 77
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 77
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 77
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 76
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 74
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 73
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 73
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 73
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 71
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 71
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 69
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 69
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 67
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 66
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 66
Potential application of berberine in the treatment of Escherichia coli sepsis 65
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 63
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 63
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 62
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 61
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 61
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 59
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 57
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 56
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 55
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 55
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 55
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 54
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 54
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 53
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 52
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 50
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 48
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 48
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 47
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 44
Totale 3.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020173 0 0 0 0 0 0 44 0 46 5 5 73
2020/2021749 53 74 102 12 72 60 87 52 71 61 68 37
2021/2022385 31 84 0 4 6 38 22 13 25 64 17 81
2022/2023657 66 83 54 44 49 76 0 28 161 3 78 15
2023/2024320 66 11 15 53 56 77 3 3 0 2 5 29
2024/2025413 112 53 46 36 40 55 71 0 0 0 0 0
Totale 3.212